// App-Quantinova.ai

: Impact of putative chemopreventative agents on prostate cancer diagnosis.

Researchers

Presenter

  • Hanan Goldberg

Principal Investigators

  • Faizan Moshin

  • Zachary William Abraham Klaassen

  • Thenappan Chandrasekar

  • Christopher Wallis

  • Jaime Omar Herrera Cceres

  • Ardalan Ahmed

  • Teck Sing Woon

  • Girish S. Kulkarni

  • Alejandro Berlin

  • Refik Saskin

  • Robert James Hamilton

  • Shabbir M.H. Alibhai

  • Neil Eric Fleshner

Medical Centers

  • University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada

  • Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada

  • University Avenue, Toronto, ON, Canada

  • Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, ON, Canada

  • Princess Margaret Hospital, Toronto, ON, Canada

  • Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • Institute of Clinical Evaluative Sciences, Toronto, ON, Canada

  • Universtiy Health Network, Toronto, ON, Canada

  • Department of Surgery, Division of Urology, University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

  • Diabetes

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • sulfonylureas

  • Metformin Hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved